Methenamine hippurate for recurrent urinary tract infections

New trial increases confidence in this non antibiotic alternative

[1]  R. Pickard,et al.  Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial , 2022, BMJ.

[2]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[3]  J. Anger,et al.  Fear and Frustration among Women with Recurrent Urinary Tract Infections: Findings from Patient Focus Groups , 2021, The Journal of urology.

[4]  P. Sand,et al.  Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial , 2021, International Urogynecology Journal.

[5]  T. Hoffmann,et al.  Uncomplicated urinary tract infection in women , 2021, BMJ.

[6]  A. Scott,et al.  Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis , 2021, The British journal of general practice : the journal of the Royal College of General Practitioners.

[7]  M. Blanker,et al.  Assessment and treatment of recurrent urinary tract infections in women: development of a questionnaire based on a qualitative study of patient expectations in secondary care , 2020, BMC Urology.

[8]  R. Chou,et al.  Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. , 2019, The Journal of urology.

[9]  Prevention of recurrent urinary tract infections in women , 2013, Drug and Therapeutics Bulletin.

[10]  B. Trautner,et al.  Diagnosis and management of recurrent urinary tract infections in non-pregnant women , 2013, BMJ.

[11]  J. Craig,et al.  Methenamine hippurate for preventing urinary tract infections. , 2002, The Cochrane database of systematic reviews.